Ipca Laboratories Limited (IPCALAB.NS)
INR 1359.3
(0.91%)
INR 1359.3
(0.91%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 18.98 Billion INR | -32.0% |
| 2022 | 32.72 Billion INR | 25.97% |
| 2021 | 25.97 Billion INR | 17.09% |
| 2020 | 22.18 Billion INR | 5.39% |
| 2019 | 21.05 Billion INR | 12.77% |
| 2018 | 18.66 Billion INR | 6.87% |
| 2017 | 17.46 Billion INR | 1.58% |
| 2016 | 17.19 Billion INR | 10.41% |
| 2015 | 15.57 Billion INR | 1.32% |
| 2014 | 15.37 Billion INR | 14.08% |
| 2013 | 13.47 Billion INR | 24.11% |
| 2012 | 10.85 Billion INR | 9.29% |
| 2011 | 9.93 Billion INR | 35.34% |
| 2010 | 7.34 Billion INR | 18.7% |
| 2009 | 6.18 Billion INR | -1.28% |
| 2008 | 6.26 Billion INR | 60.0% |
| 2007 | 3.91 Billion INR | 8.44% |
| 2006 | 3.61 Billion INR | 191.31% |
| 2005 | 1.23 Billion INR | 19.07% |
| 2004 | 1.04 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.68 Billion INR | -28.76% |
| 2023 FY | 22.25 Billion INR | -32.0% |
| 2023 Q1 | 8.33 Billion INR | 3.08% |
| 2023 Q2 | 11.25 Billion INR | 34.96% |
| 2023 Q3 | 11.24 Billion INR | -0.12% |
| 2023 Q4 | 6.84 Billion INR | -39.08% |
| 2022 Q2 | 8.29 Billion INR | 3.73% |
| 2022 Q3 | 8.34 Billion INR | 0.68% |
| 2022 Q4 | 8.08 Billion INR | -3.11% |
| 2022 FY | 32.72 Billion INR | 25.97% |
| 2022 Q1 | 7.99 Billion INR | 41.7% |
| 2021 Q4 | 5.64 Billion INR | -17.36% |
| 2021 Q1 | 6.59 Billion INR | 42.78% |
| 2021 Q2 | 6.91 Billion INR | 4.85% |
| 2021 Q3 | 6.82 Billion INR | -1.25% |
| 2021 FY | 25.97 Billion INR | 17.09% |
| 2020 FY | 22.18 Billion INR | 5.39% |
| 2020 Q4 | 4.61 Billion INR | -20.52% |
| 2020 Q3 | 5.81 Billion INR | -4.65% |
| 2020 Q2 | 6.09 Billion INR | 8.14% |
| 2020 Q1 | 5.63 Billion INR | 40.36% |
| 2019 FY | 21.05 Billion INR | 12.77% |
| 2019 Q4 | 4.01 Billion INR | -29.1% |
| 2019 Q3 | 5.66 Billion INR | -8.37% |
| 2019 Q2 | 6.17 Billion INR | 18.93% |
| 2019 Q1 | 5.19 Billion INR | 75.61% |
| 2018 Q2 | 5.7 Billion INR | 9.27% |
| 2018 Q1 | 5.21 Billion INR | 0.0% |
| 2018 FY | 18.66 Billion INR | 6.87% |
| 2018 Q4 | 2.95 Billion INR | -38.18% |
| 2018 Q3 | 4.78 Billion INR | -16.1% |
| 2017 FY | 17.46 Billion INR | 1.58% |
| 2016 FY | 17.19 Billion INR | 10.41% |
| 2015 FY | 15.57 Billion INR | 1.32% |
| 2014 FY | 15.37 Billion INR | 14.08% |
| 2013 FY | 13.47 Billion INR | 24.11% |
| 2012 FY | 10.85 Billion INR | 9.29% |
| 2011 FY | 9.93 Billion INR | 35.34% |
| 2010 FY | 7.34 Billion INR | 18.7% |
| 2009 FY | 6.18 Billion INR | -1.28% |
| 2008 FY | 6.26 Billion INR | 60.0% |
| 2007 FY | 3.91 Billion INR | 8.44% |
| 2006 FY | 3.61 Billion INR | 191.31% |
| 2005 FY | 1.23 Billion INR | 19.07% |
| 2004 FY | 1.04 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eris Lifesciences Limited | 4.94 Billion INR | -284.136% |
| Shilpa Medicare Limited | 3.33 Billion INR | -469.484% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -643.416% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -28.359% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -133493.189% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -517.603% |
| Alkem Laboratories Limited | 32.83 Billion INR | 42.173% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -19.647% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -667.641% |
| Divi's Laboratories Limited | 14.17 Billion INR | -33.999% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -4067.74% |
| Bal Pharma Limited | 555.62 Million INR | -3317.335% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 65.885% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -1237.888% |
| Brooks Laboratories Limited | 51.18 Million INR | -36999.648% |
| FDC Limited | 3.49 Billion INR | -442.54% |
| Granules India Limited | 10.31 Billion INR | -84.117% |
| Hester Biosciences Limited | 908.84 Million INR | -1989.213% |
| Ind-Swift Limited | 946.56 Million INR | -1905.944% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -4229.632% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -31.366% |
| Laurus Labs Limited | 11.9 Billion INR | -59.428% |
| Medico Remedies Limited | 59.67 Million INR | -31718.349% |
| Morepen Laboratories Limited | 1.98 Billion INR | -855.375% |
| Orchid Pharma Limited | 800.77 Million INR | -2271.165% |
| Vaishali Pharma Limited | 84.02 Million INR | -22496.485% |
| Sequent Scientific Limited | 2.9 Billion INR | -554.336% |
| Sigachi Industries Limited | 579.88 Million INR | -3174.362% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -1253.561% |
| Valiant Laboratories Limited | 138.02 Million INR | -13656.24% |
| Windlas Biotech Limited | 1 Billion INR | -1786.479% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1774.286% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 84.836% |
| Aarti Drugs Limited | 1.16 Billion INR | -1526.376% |
| Ajanta Pharma Limited | 30.46 Billion INR | 37.669% |
| Alembic Limited | 872.45 Million INR | -2076.334% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -806.746% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1827.0% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -278310.557% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -773.194% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 80.196% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -63.114% |
| Hikal Limited | 4.46 Billion INR | -325.369% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -793.877% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -4503.869% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -11604.268% |
| Medicamen Biotech Limited | 335.16 Million INR | -5565.116% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1935.767% |
| Neuland Laboratories Limited | 2.92 Billion INR | -548.097% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -32475.477% |
| RPG Life Sciences Limited | 1.63 Billion INR | -1060.966% |
| Unichem Laboratories Limited | 6.72 Billion INR | -182.307% |
| Venus Remedies Limited | 1.91 Billion INR | -890.855% |
| Wanbury Limited | 978.96 Million INR | -1839.557% |
| Wockhardt Limited | 8.48 Billion INR | -123.91% |
| Innova Captab Limited | 931.03 Million INR | -1939.419% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -533.892% |
| Themis Medicare Limited | 1.12 Billion INR | -1586.59% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -762.681% |
| Mankind Pharma Limited | 29.27 Billion INR | 35.136% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 59.56% |
| Sakar Healthcare Limited | 204.07 Million INR | -9204.044% |
| Albert David Limited | 1.02 Billion INR | -1750.378% |
| Lupin Limited | 125.09 Billion INR | 84.822% |
| Gufic Biosciences Limited | 1.18 Billion INR | -1500.183% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 87.685% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1667.627% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -5393.573% |
| Piramal Enterprises Limited | 63.65 Billion INR | 70.17% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 11.364% |
| NATCO Pharma Limited | 10.05 Billion INR | -88.781% |
| Suven Life Sciences Limited | 109.75 Million INR | -17200.774% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -41037.88% |
| Strides Pharma Science Limited | 9.16 Billion INR | -107.236% |
| Indoco Remedies Limited | 12.06 Billion INR | -57.427% |
| Alpa Laboratories Limited | 127.38 Million INR | -14806.265% |
| Lasa Supergenerics Limited | 291.17 Million INR | -6421.049% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -517.122% |